INTS stock

Are Intensity Therapeutics Inc (INTS) shares a good deal now?

Cameron Mitchell

While Intensity Therapeutics Inc has underperformed by -2.34%, investors are advised to look at stock chart patterns for technical insight. ...

Investing in Intensity Therapeutics Inc (INTS) might be a great opportunity, but the stock is a bit overvalued

Cameron Mitchell

While Intensity Therapeutics Inc has overperformed by 1.38%, investors are advised to look at stock chart patterns for technical insight. ...

Investing in Intensity Therapeutics Inc (INTS) might be a great opportunity, but the stock is a bit undervalued

Cameron Mitchell

While Intensity Therapeutics Inc has underperformed by -0.79%, investors are advised to look at stock chart patterns for technical insight. ...

Investing in Intensity Therapeutics Inc (INTS) might be a great opportunity, but the stock is a bit undervalued

Cameron Mitchell

While Intensity Therapeutics Inc has underperformed by -0.79%, investors are advised to look at stock chart patterns for technical insight. ...

Investing in Intensity Therapeutics Inc (INTS) might be a great opportunity, but the stock is a bit undervalued

Cameron Mitchell

While Intensity Therapeutics Inc has underperformed by -0.79%, investors are advised to look at stock chart patterns for technical insight. ...

Will Intensity Therapeutics Inc (INTS) meet earnings estimates this quarter?

Patricia Turner

Intensity Therapeutics Inc (INTS)’s stock has witnessed a price hike of 0.48% from the previous close with its current price ...

Should investors be concerned about INTS’s high price-to-sales ratio?

Arcelia Reed

Intensity Therapeutics Inc (INTS)’s stock is trading at $0.36 at the moment marking a fall of -3.12% from the last ...

Is INTS’s price to cash per share ratio a concern for investors?

Patricia Turner

In the current trading session, Intensity Therapeutics Inc’s (INTS) stock is trading at the price of $0.39, a fall of ...

INTS’s price-to-sales ratio: Is it a good investment opportunity?

Arcelia Reed

Intensity Therapeutics Inc (INTS)’s stock is trading at $0.46 at the moment marking a rise of 5.30% from the last ...

INTS’s price-to-sales ratio: Is it a good investment opportunity?

Arcelia Reed

Intensity Therapeutics Inc (INTS)’s stock is trading at $0.41 at the moment marking a fall of -2.22% from the last ...

12 Next
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.